• Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta
• Bone allografting: an original method for biological osteosynthesis and bone reinforcement in children with osteogenesis imperfecta
• Case Report: A Novel Homozygous Variant of the <em>SERPINF1</em> Gene in Rare Osteogenesis Imperfecta Type VI
• Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate
• Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses
• CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII
• Cyclic intravenous pamidronate for an infant with osteogenesis imperfecta type II
• Deep intronic mutation in CRTAP results in unstable isoforms of the protein to induce type I collagen aggregation in a lethal type of osteogenesis imperfecta type VII
• Dental and craniofacial defects in the Crtap(-/-) mouse model of osteogenesis imperfecta type VII
• Dental and craniofacial defects in the Crtap^-/- mouse model of osteogenesis imperfecta type VII
• Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta
• Intracranial aneurysm as a possible complication of osteogenesis imperfecta: a case series and literature review
• Intravenous pamidronate in osteogenesis imperfecta type VII
• Keratoconus tomographic indices in osteogenesis imperfecta
• Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI
• Osteogenesis imperfecta type VII maps to the short arm of chromosome 3
• Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease
• Osteogenesis imperfecta type VIII: highlighting the need for genetic testing
• Outcomes of Pediatric Osteogenesis Imperfecta Patients Requiring Port-a-Cath Placement for Long-Term Vascular Access
• Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients
• RNA Sequencing of Urine-Derived Cells for the Characterization and Diagnosis of Osteogenesis Imperfecta
• TAPT1-at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta
• Whole-Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta